Severe scratching in spinocerebellar ataxia 17: Another case

Fördermittel

MGP: The author is supported by the section of medicine of the University of Lübeck (CS06-2020). She is a member of the European Reference Network for Rare Neurological Diseases – Project ID No 739510. AM: Commercial research support: Pharm Allergan, Ipsen, Merz Pharmaceuticals, Actelion; Honoraria for lectures: Actelion, GlaxoSmithKline, Desitin and Teva; Support from Foundations: Possehl-Stiftung (Lübeck, Germany), Margot und Jürgen Wessel Stiftung (Lübeck, Germany), Tourette Syndrome Association (Germany), Interessenverband Tourette Syndrom (Germany), CHDI; Academic research support: Deutsche Forschungsgemeinschaft (DFG): projects 1692/3-1, 4-1, SFB 936, and FOR 2698 (project numbers 396914663, 396577296, 396474989), Innovationsauss-chuss of the Gemeinsamer Bundesausschuss: Translate NAMSE (structural support for the Lübeck Center for Rare NB: The author received speaker’s honoraria from Grü-nenthal, UCB, Abbvie and Teva. He served as a consultant for Censa Pharmaceuticals and Centogene. He received non-financial support from Bayer. NB is funded by the DFG (BR4328.2-1, GRK1957), the Collaborative Center for X-linked Dystonia-Parkinsonism and the Else-Kröner Fresenius-Stiftung (HA17_2017).